Skip to content

Clinical trials

Hyperparathyroidism, Secondary trials in the United States with no applicable phase

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hyperparathyroidism, Secondary Phase: Not applicable Country / region: United States Clear all

6 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20072
20092
20111

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed5
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Denver Nephrologists, P.C.1
Mayo Clinic1
Roxane Laboratories1
University of California, Los Angeles1
University of Maryland, Baltimore1
University of Virginia1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hyperparathyroidism, Secondary6
Renal Insufficiency, Chronic3
Hyperparathyroidism2
Hypocalcemia1
Inflammation1
Kidney Failure, Chronic1
Proteinuria1
Pulmonary Fibrosis1
Vascular Calcification1
Vitamin D Deficiency1

Trials

Showing 1 to 6 of 6. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.